Table: begin end state 1 16 cytoplasmic 17 36 transmembrane 37 41 non-cytoplasmic 42 59 transmembrane 60 70 cytoplasmic 71 88 transmembrane 89 99 non-cytoplasmic 100 118 transmembrane 119 124 cytoplasmic 125 144 transmembrane 145 173 non-cytoplasmic 174 192 transmembrane 193 270 cytoplasmic 271 291 transmembrane 292 296 non-cytoplasmic 297 315 transmembrane 316 339 cytoplasmic 340 356 transmembrane 357 360 non-cytoplasmic 361 382 transmembrane 383 390 cytoplasmic 391 427 transmembrane 428 446 cytoplasmic 447 479 transmembrane 480 484 non-cytoplasmic 485 503 transmembrane 504 508 cytoplasmic 509 529 transmembrane 530 532 non-cytoplasmic 533 556 transmembrane 557 566 cytoplasmic 567 588 transmembrane 589 597 non-cytoplasmic 598 621 transmembrane 622 630 cytoplasmic 631 660 transmembrane 661 661 cytoplasmic 662 674 non-cytoplasmic
Input: >GFF84 FitnessBrowser__psRCH2:GFF84 MSESQGLHASPSEWPRALFYVALLFSIYQIVTAAFHPVSSQVLRAGHVGFLLLLVFLCYP ARGNGKPFQPVAWLLGLAGFATFFYQWYFEADLIQRSGDMTTADMVVGLTLIVLVFEAAR RVMGIALPIICALFLAYGLLGEYLPGDLAHRGYYLDQIVNQLSFGTEGLYGTPTYVSATY IFLFILFGSFLEQAGMIKLFTDFAMGLFGHKLGGPAKVSVVSSALMGTITGSGVANVVTT GQFTIPLMKRFGYRPAFAGGVEATSSMGSQIMPPVMGAVAFIMAETINVPFVEIAKAALI PALLYFGSVFWMVHLEAKRAGLKGLPKDECPSAMAAVKERWYLLIPLVVLVWLLFSGRTP MFAGTIGLALTAIVILGSAIILKVSNFALRIAFWIALGLLCAGFFQLGIGVIFGVIAALV AVCWFIKGGRDTLVICLHALVEGARHAVPVGIACALVGVIIGVVSLTGVASTFAGYILAV GENNLFLSLLLTMLTCLVLGMGIPTIPNYIITSSIAAPALLDLGVPLIVSHMFVFYFGIM ADLTPPVALACFAAAPIAKERGLKISMWAIRIAIAGFIVPFMAVYNPALMMQGGDWGATL YMLFKAAFAVGLWGAVFTGYLQRPMALWEKVLAFAAAASMVLAMPISDEIGFALGALFLI QHIWRARRAEPATA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server